despit
effort
prevent
worldwid
includ
recent
advanc
vaccin
therapi
childhood
commun
acquir
pneumonia
cap
remain
major
caus
morbid
mortal
develop
develop
world
tradit
qualifi
aetiolog
cap
prove
fraught
challeng
particularli
due
low
yield
blood
sputum
specimen
recent
year
howev
new
advanc
techniqu
enzymelink
immunosorb
assay
polymeras
chain
reaction
dramat
improv
detect
rate
bacteria
virus
addit
qualifi
true
burden
diseas
known
organ
streptococcu
pneumonia
led
identif
organ
human
bocaviru
previous
associ
cap
articl
aim
provid
brief
updat
clinician
current
epidemiolog
cap
postvaccin
era
base
combin
recommend
exist
clinic
practic
guidelin
recent
systemat
review
current
literatur
childhood
commun
acquir
pneumonia
cap
defin
infect
affect
individu
age
year
whose
lung
inflict
spectrum
pathogen
acquir
outsid
hospit
set
subsequ
result
inflamm
affect
lung
tissu
clinic
defin
presenc
sign
symptom
pneumonia
fever
tachypnoea
cough
previous
well
child
young
children
symptom
may
nonspecif
current
spite
limit
accuraci
chest
xray
remain
mainstay
diagnosi
childhood
cap
radiograph
find
consolid
typic
use
verifi
diagnosi
develop
countri
absolut
good
clinic
assess
may
precipit
empir
treatment
cap
investig
develop
world
difficulti
obtain
xray
emphasi
place
clinic
assess
whilst
inclus
respons
pathogen
ideal
definit
cap
current
techniqu
yet
obtain
suffici
sensit
detect
relev
organ
consequ
signific
proport
case
pathogen
identifi
find
mirror
mani
prospect
epidemiolog
studi
involv
numer
specimen
type
blood
sputum
rais
assumpt
pose
challeng
adopt
evidencebas
approach
manag
cap
particular
appropri
antibiot
andor
antivir
use
resultantli
measur
blood
white
cell
count
c
reactiv
protein
util
proxi
guid
us
natur
sever
infect
whilst
regard
use
measur
necessarili
allow
us
direct
treatment
toward
specif
pathogen
commonli
result
viral
pneumonia
treat
unnecessarili
antibiot
stratifi
clear
need
better
diagnost
method
spite
recent
advanc
vaccin
therapi
environment
modif
treatment
underli
diseas
promot
extens
past
decad
childhood
cap
continu
attribut
signific
morbid
mortal
worldwid
cap
affect
million
peopl
year
region
world
disproport
childhood
cap
affect
million
children
per
year
lead
million
death
per
year
cap
continu
estim
lead
singl
caus
childhood
mortal
world
recent
data
suggest
number
children
sever
cap
increas
worldwid
difficulti
continu
persist
produc
evidencebas
estim
due
part
absenc
simpl
investig
full
accuraci
identifi
children
cap
varianc
cap
case
definit
low
specif
verbal
autopsi
cap
similar
clinic
pictur
pneumonia
malaria
difficulti
differenti
cap
neonat
sepsi
diagnosi
base
clinic
assess
verif
chest
xray
figur
whilst
countri
spare
morbid
mortal
cap
disproport
episod
occur
develop
countri
figur
remain
lead
caus
death
amongst
children
lowincom
countri
countri
world
account
million
episod
episod
current
half
world
annual
new
cap
case
concentr
india
million
china
million
pakistan
million
bangladesh
indonesia
nigeria
million
cap
attribut
combin
exposur
risk
factor
relat
host
environ
result
infect
tabl
risk
factor
parent
smoke
common
develop
develop
countri
whilst
other
malnutrit
lack
immun
specif
develop
countri
exacerb
dispar
worldwid
burden
cap
though
incid
cap
vari
wide
amongst
develop
countri
develop
region
north
america
europ
share
similar
incid
figur
exampl
annual
incid
cap
children
year
age
north
america
case
per
per
year
strongli
correl
incid
europ
finland
incid
case
per
children
per
year
unit
kingdom
uk
incid
figur
lower
case
per
per
year
children
year
age
whilst
incid
may
seem
small
comparison
europ
north
america
note
rate
deriv
region
hospitalbas
audit
exclud
children
year
age
treat
commun
signific
proport
case
may
lie
data
difficult
collect
cap
continu
seen
commonli
children
younger
year
age
illustr
finland
incid
fall
case
per
per
year
children
older
year
age
worldwid
cap
attribut
death
children
age
group
world
health
organ
estim
one
three
newborn
infant
death
occur
due
pneumonia
alongsid
risk
factor
long
term
morbid
mortal
cap
includ
prematur
lowbirthweight
immunocompromis
children
known
underli
condit
cystic
fibrosi
congenit
heart
diseas
asthma
incident
previou
upper
respiratori
tract
infect
urti
also
independ
associ
childhood
cap
strong
correl
increas
number
urti
lead
rise
cap
episod
possibl
due
higher
infect
suscept
cap
caus
wide
varieti
organ
bacteri
viral
due
absenc
accur
fast
wide
avail
afford
diagnost
tool
identif
caus
risk
factor
relat
host
environ
affect
incid
childhood
clinic
pneumonia
commun
epidemiolog
studi
conduct
delin
aetiolog
cap
segreg
two
studi
form
tradit
prospect
hospitalbas
studi
reli
blood
cultur
occasion
percutan
lung
aspir
bronchoalveolar
lavag
bal
approach
lack
sensit
due
part
low
yield
blood
cultur
difficulti
obtain
adequ
sputum
sampl
reluct
perform
lung
aspir
bal
children
furthermor
even
rigor
conduct
studi
generaliz
find
question
due
numer
confound
season
set
age
children
local
criteria
hospit
admiss
whether
coincid
particular
epidem
difficult
control
type
studi
discontinu
recent
year
use
newer
method
improv
previou
techniqu
indirect
immunofluoresc
enzymelink
immunosorb
assay
polymeras
chain
reaction
pcr
examin
nasopharyng
specimen
serolog
pair
sampl
improv
respiratori
viral
identif
pneumococc
detect
blood
advanc
vaccin
therapi
estim
studi
involv
vaccin
commonplac
number
cap
case
prevent
specif
vaccin
presum
minimum
estim
preval
cap
due
organ
vaccin
direct
caus
organ
vari
accord
child
age
virus
commonest
children
year
old
bacteri
caus
report
common
older
children
signific
number
case
cap
continu
repres
mix
infect
comprehens
studi
find
mix
viralbacteri
infect
case
tabl
virus
remain
commonest
caus
cap
young
children
overal
virus
account
case
frequent
children
year
age
recent
vaccin
probe
studi
children
year
age
clinic
diagnosi
cap
pneumococcu
identifi
respiratori
syncyti
viru
rsv
rsv
remain
lead
viral
caus
identifi
cap
bronchiol
case
admit
hospit
develop
countri
spite
difficulti
detect
due
fragil
found
signific
frequenc
climat
geograph
area
sharp
peak
activ
period
month
season
vari
consider
region
peak
typic
occur
winter
season
temper
climat
raini
season
tropic
climat
primari
respiratori
infect
caus
rsv
attribut
increas
risk
secondari
bacteri
infect
viral
bacteri
coinfect
common
find
approxim
childhood
cap
episod
addit
episod
wheez
due
reactiv
airway
commonli
seen
risk
cap
bronchiol
caus
rsv
highest
among
children
age
less
year
major
episod
occur
first
year
life
commonli
boy
sever
diseas
occur
infant
age
week
month
spite
new
vaccin
develop
rsv
continu
signific
potenti
deadli
pathogen
caus
childhood
cap
alon
mix
infect
bacteri
caus
influenza
follow
close
rsv
caus
signific
morbid
mortal
childhood
cap
influenza
rais
forefront
epidemiolog
indic
partli
due
improv
detect
rate
previous
detect
rel
infrequ
paediatr
pneumonia
use
immunofluoresc
viral
pcr
diagnost
yield
viru
doubl
caus
onethird
viral
cap
case
rate
compar
rsv
cap
prospect
epidemiolog
studi
uk
winter
influenza
season
children
diagnos
cap
note
influenza
measur
durat
fever
hospit
stay
total
durat
ill
clinic
burden
influenza
cap
compar
rsv
cap
human
immunodefici
viru
hiv
past
decad
hiv
epidem
partli
blame
increas
incid
mortal
childhood
cap
bacteri
superinfect
mainstay
caus
childhood
mortal
comparison
uninfect
children
pathogen
pneumocysti
jiroveci
mycoplasma
tuberculosi
remain
import
caus
childhood
cap
though
routin
vaccin
provid
lower
efficaci
hiv
infect
children
still
abl
mount
suffici
immun
respons
protect
substanti
proport
cap
caus
specif
pathogen
antiretrovir
treatment
use
cotrimoxazol
prophylaxi
note
reduc
incid
sever
hivassoci
cap
virus
increasingli
common
newli
identifi
virus
human
metapneumoviru
human
bocaviru
found
approxim
cap
case
respect
virus
isol
children
diagnos
cap
includ
adenoviru
rhinoviru
varicella
zoster
viru
cytomegaloviru
herp
simplex
viru
enterovirus
time
caus
prevent
routin
immun
streptococcu
pneumonia
pneumonia
pneumonia
major
caus
mortal
morbid
develop
industri
countri
especi
among
young
children
immunocompromis
immunocompet
individu
implic
invas
eg
meningococc
diseas
septicaemia
well
noninvas
diseas
cap
otiti
media
burden
pneumococc
diseas
consider
incid
rate
invas
noninvas
diseas
peak
children
year
age
recent
systemat
review
meta
analys
pneumonia
frequent
isol
agent
confid
interv
ci
pneumococc
serotyp
preval
ci
confirm
numer
prospect
microbiologybas
studi
pneumococcu
identifi
cap
case
diagnos
prior
introduct
pneumococc
vaccin
annual
incid
childhood
cap
per
children
age
year
per
children
age
year
evidenc
remark
consist
prospect
studi
norway
uk
introduct
proteinpolysaccharid
vaccin
burden
diseas
caus
pneumonia
fallen
dramat
fall
also
appli
encapsul
bacteria
haemophilu
influenza
neisseria
meningitidi
salmonella
typhi
uk
infant
vaccin
sevenval
pneumococc
conjug
vaccin
pcv
start
nation
time
trend
studi
shown
decreas
admiss
rate
countri
unit
state
america
usa
pcv
avail
longer
decreas
hospit
admiss
approxim
report
introduct
thirteenval
pneumococc
conjug
vaccin
pcv
worldwid
come
year
clinic
suspicion
bacteri
cap
fulli
vaccin
child
like
fall
advent
pneumococc
vaccin
sever
equivoc
find
whilst
incid
invas
pneumococc
diseas
includ
bacteri
cap
declin
chang
noninvas
pulmonari
diseas
shown
similar
declin
furthermor
rate
local
complic
associ
cap
includ
preval
empyema
surprisingli
increas
age
group
hypothes
due
chang
circul
pneumococc
strain
may
produc
differenti
chang
diseas
incid
diseas
present
sever
popul
haemophilu
influenza
h
influenza
h
influenza
type
b
hib
current
remain
second
common
bacteri
organ
respons
cap
numer
studi
particularli
blood
cultur
base
isol
organ
childhood
cap
case
controversi
surround
role
nontyp
h
influenza
nthi
sever
studi
pakistan
papua
new
guinea
note
common
blood
cultur
lung
aspir
note
find
yet
replic
elsewher
staphylococcu
aureu
aureu
pneumonia
h
influenza
aureu
third
common
bacteri
organ
isol
cap
usa
aureu
increas
frequenc
past
decad
mani
attribut
commun
acquir
methicillinresist
aureu
mrsa
isol
approxim
case
viral
coinfect
attribut
caus
respiratori
failur
worldwid
recent
complet
studi
sever
cap
aureu
identifi
case
case
make
second
largest
caus
studi
furthermor
epidemiolog
studi
involv
lung
aspir
chile
util
sampl
size
children
includ
normal
control
aureu
identifi
main
pathogen
other
organ
salmonella
spp
mycoplasma
pneumonia
mycobacterium
tuberculosi
chlamydia
spp
pseudomona
spp
escherichia
coli
measl
varicella
influenza
histoplasmosi
toxoplasmosi
also
caus
cap
whilst
infect
mani
organ
yet
prevent
worldwid
immun
effort
measl
influenza
bacil
calmetteegu
erin
bcg
reproduc
permiss
british
thorac
societi
guidelin
manag
commun
acquir
pneumonia
children
updat
definit
includ
clinic
find
compat
cap
togeth
radiolog
chang
column
percentag
indic
percentag
cap
case
organ
detect
viral
bacteri
isol
detect
classifi
mix
indic
separ
column
studi
possibl
determin
whether
infect
singl
mix
indic
bacteri
isol
includ
isol
sputum
upper
respiratori
tract
specimen
absenc
evid
signific
exampl
rise
antibodi
concentr
pneumococcu
associ
contribut
declin
worldwid
cap
burden
caus
neonat
pneumonia
develop
countri
yet
studi
extens
howev
sever
studi
neonat
sepsi
suggest
includ
gramneg
enter
organ
particular
klebsiella
spp
gramposit
organ
pneumococcu
group
b
streptococcu
aureu
investig
manag
cap
beyond
scope
articl
reader
refer
current
bt
guidelin
manag
childhood
cap
read
summari
howev
aim
highlight
sever
key
learn
point
import
preclud
read
though
clinic
featur
cap
specif
aetiolog
sever
key
featur
increas
clinic
suspicion
child
present
cap
list
nation
institut
health
clinic
excel
nice
tabl
tabl
recent
cochran
review
suggest
investig
children
clinic
featur
cap
unnecessari
treatment
may
start
empir
base
medic
assess
whilst
chest
xray
find
help
specifi
aetiolog
world
health
organis
produc
method
standard
interpret
chest
radiograph
children
previous
sequenti
rise
acut
phase
reactant
suspect
mean
differenti
aetiolog
andor
sever
cap
howev
new
evid
note
clinic
util
distinguish
viral
bacteri
infect
util
routin
test
current
evid
state
fulli
vaccin
children
less
year
old
present
mild
symptom
lrti
necessarili
need
treat
antibiot
howev
review
symptom
persist
bacteri
viral
pneumonia
may
reliabl
distinguish
clinic
featur
children
clear
clinic
diagnosi
cap
receiv
antibiot
oral
amoxicillin
remain
antibiot
choic
effect
well
toler
cheap
current
statist
note
approxim
one
four
children
cap
requir
hospit
whilst
note
high
rate
intraven
antibiot
administr
children
admit
hospit
cap
oral
amoxicillin
antibiot
choic
administ
first
line
treatment
intraven
antibiot
reserv
children
unabl
absorb
oral
medic
present
complic
cap
septicaemia
evid
also
note
chest
physiotherapi
although
still
practic
unit
kingdom
benefit
perform
children
cap
simpl
oral
antibiot
support
care
like
effect
major
children
cap
approxim
million
new
episod
childhood
cap
occur
global
per
year
occur
develop
countri
spite
advanc
undertaken
reach
millenium
develop
goal
approxim
million
death
cap
occur
year
children
age
less
year
age
mainli
african
southeast
asia
region
whilst
evid
base
estim
import
caus
organ
vari
differ
set
main
caus
cap
worldwid
rsv
pneumonia
hib
futur
studi
advanc
current
techniqu
develop
better
method
detect
infect
wider
rang
pathogen
broaden
understand
caus
cap
elucid
new
vaccin
develop
